Kobayashi Pharmaceutical News and Activities
Presence
Kobayashi Pharmaceutical develops and sells consumer healthcare, hygiene, and household products. Its main products include over the counter medicines, oral care, and wellness items for everyday consumers and retail customers.
Kobayashi Pharmaceutical products and services overview:
- OTC medicines
- Oral care
- Skin care
- Household hygiene
- Wellness products
- Medical devices
Revenue: ~$1 billion
Employees: 3,500
Headquarters: Osaka, Japan
Kobayashi Pharmaceutical is one of the...
Kobayashi Pharmaceutical is a company listed under the stock ticker 4967 (JP).
Executives
View the org chart displaying its 11 main executives
Most searched biographies at Kobayashi Pharmaceutical
- Norikazu Toyota, President, Chief Executive Officer, Representativ...
- Shinsuke Matsumoto, Independent Director
- Yoshiro Katae, Independent Director
Create your alert
to follow the executive moves at Kobayashi Pharmaceutical.
Pharmaceuticals
Kobayashi Pharmaceutical has 1,913 competitors including Sanofi (France), Eli Lilly (United States (USA)) and Moderna (United States (USA)).
Popular M&A news in Pharmaceuticals
- Contraline has just announced a $93 Million fundraising (posted on June 3 2026).
- Hims & Hers has acquired Eucalyptus (posted on June 2 2026).
- Apotex has filed its IPO. Its stock ticker will be TSX. (posted on June 2 2026).
Popular contacts in Pharmaceuticals
News
Press releases by Kobayashi Pharmaceutical
Social media about Kobayashi Pharmaceutical
- Kobayashi Pharmaceutical on Wikipedia, Google News & Yahoo Finance
- Kobayashi Pharmaceutical on LinkedIn, X (Twitter) & YouTube
